Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

JNJ Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: May 01, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Johnson & Johnson (JNJ)

Based on 32 analysts giving stock ratings to Johnson & Johnson in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
19
Buy
40
Hold
41
Sell
0
Strong Sell
0
Johnson & Johnson

Johnson & Johnson. Stock Analysis JNJ

United States Health Care Mega Cap Report:
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 138,200 full-time employees. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).
Read More

Johnson & Johnson (JNJ) Chart

Key Statistics of Johnson & Johnson (JNJ)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$234.35$239.80

Today's Open

$235.64

Volume

11.80M

P/E Ratio (TTM)

21.13

52 Week Range

$149.04$251.71

Market Cap

557.82B

Avg. Volume

8.26M

Dividend Yield

2.21%

Financial Metrics & Statements of Johnson & Johnson (JNJ)

Super Investors Invested in Johnson & Johnson (JNJ)

View All

Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.

lock-image

FAQ's for Johnson & Johnson (JNJ)

  • According to Musaffa’s Shariah screening methodology, Johnson & Johnson (JNJ) is currently classified as HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Johnson & Johnson using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Johnson & Johnson if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Johnson & Johnson by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Johnson & Johnson may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Johnson & Johnson on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.